Gland Pharma Ltd - Stock Price

As on23 Sep 2021 03:59 PM Closed
  • BSE : 543245
  • ISIN CODE : INE068V01023
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Gland Pharma Ltd is not traded on BSE/NSE
+0.72 %+28.1
+0.95 %+36.8

Balance Sheet

Parameter MAR 21  MAR 20  YoY %Change
Share Capital163.59154.955.58
    Equity - Authorised500.00500.000.00
    Equity - Issued163.59154.955.58
    Equity Paid Up163.59154.955.58
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value1.001.000.00
Share Warrants & Outstandings254.21164.8454.22
Total Reserves58614.6236142.5662.18
    Securities Premium18401.095889.94212.42
    Capital Reserves0.000.000.00
    Profit & Loss Account Balance40226.8130257.1832.95
    General Reserves31.2231.220.00
    Other Reserves-44.50-35.78-24.37
Reserve excluding Revaluation Reserve58614.6236142.5662.18
Revaluation reserve0.000.000.00
Shareholder's Funds59032.4236462.3561.90
Minority Interest0.000.000.00
Long-Term Borrowings0.000.000.00
Secured Loans0.000.000.00
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks0.000.000.00
    Term Loans - Institutions0.000.000.00
    Other Secured0.000.000.00
Unsecured Loans39.3440.69-3.32
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.
    Loans - Others0.000.000.00
    Other Unsecured Loan39.3440.69-3.32
Deferred Tax Assets / Liabilities738.81740.54-0.23
    Deferred Tax Assets60.2060.46-0.43
    Deferred Tax Liability799.01801.00-0.25
Other Long Term Liabilities24.9726.58-6.06
Long Term Trade Payables0.000.000.00
Long Term Provisions0.000.000.00
Total Non-Current Liabilities803.12807.81-0.58
Current LiabilitiesNANANA
Trade Payables4007.252490.9460.87
    Sundry Creditors4007.252490.9460.87
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities579.81817.27-29.06
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers342.47342.310.05
    Interest Accrued But Not Due0.000.000.00
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities237.34474.96-50.03
Short Term Borrowings0.000.000.00
    Secured ST Loans repayable on Demands0.000.000.00
    Working Capital Loans- Sec0.000.000.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans0.000.000.00
Short Term Provisions538.22282.0290.84
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax286.90107.23167.56
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions251.32174.7943.78
Total Current Liabilities5125.283590.2342.76
Total Liabilities64960.8240860.3958.98
Gross Block14306.9713478.096.15
Less: Accumulated Depreciation4764.653797.0925.48
Less: Impairment of Assets0.000.000.00
Net Block9542.329681.00-1.43
Lease Adjustment A/c0.000.000.00
Capital Work in Progress3378.061884.6679.24
Non Current Investments0.000.000.00
Long Term Investment0.000.000.00
Long Term Loans & Advances779.74815.22-4.35
Other Non Current Assets24.2816.6146.18
Total Non-Current Assets13724.4012397.4910.70
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Raw Materials5304.013024.3575.38
    Work-in Progress3639.771976.8684.12
    Finished Goods1696.81640.91164.75
    Packing Materials1717.231556.8210.30
    Stores  and Spare330.61298.6410.71
    Other Inventory63.2565.21-3.01
Sundry Debtors6709.716017.8511.50
    Debtors more than Six months0.000.000.00
    Debtors Others6723.926071.4510.75
Cash and Bank30057.5013251.93126.82
    Cash in hand0.210.67-68.66
    Balances at Bank30057.2913251.26126.83
    Other cash and bank balances0.000.000.00
Other Current Assets841.51712.3218.14
    Interest accrued on Investments387.90147.78162.48
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses109.1191.2219.61
    Other current_assets344.50473.32-27.22
Short Term Loans and Advances876.02918.01-4.57
    Advances recoverable in cash or in kind129.97150.74-13.78
    Advance income tax and TDS0.0095.35-100.00
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances746.05671.9211.03
Total Current Assets51236.4228462.9080.01
Net Current Assets (Including Current Investments)46111.1424872.6785.39
Miscellaneous Expenses not written off0.000.000.00
Total Assets64960.8240860.3958.98
Contingent Liabilities747.02118.34531.25
Total Debt40.6949.60-17.96
Book Value359.30234.2553.38
Adjusted Book Value359.30234.2553.38

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 3908.85. Its current market capitalisation stands at Rs 64197.85 Cr. In the latest quarter, company has reported Gross Sales of Rs. 34628.76 Cr and Total Income of Rs.35976.52 Cr. The company's management includes Allen Zhang, Udo Jahannes Vetter, Yifang Wu, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Naina Lal Kidwai, Xiaohui Guan, Dongming Li, Qiyu Chen, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

Latest News